BRANGANI, Corinna
 Distribuzione geografica
Continente #
EU - Europa 1.225
NA - Nord America 710
AS - Asia 334
AF - Africa 11
SA - Sud America 3
OC - Oceania 1
Totale 2.284
Nazione #
GB - Regno Unito 739
US - Stati Uniti d'America 701
CN - Cina 204
IT - Italia 169
SG - Singapore 68
SE - Svezia 64
IE - Irlanda 57
FI - Finlandia 41
RU - Federazione Russa 41
DE - Germania 39
FR - Francia 37
KR - Corea 23
VN - Vietnam 12
JP - Giappone 9
GR - Grecia 8
CA - Canada 7
UA - Ucraina 7
BE - Belgio 6
GH - Ghana 6
ID - Indonesia 6
NL - Olanda 5
RO - Romania 5
BR - Brasile 3
TR - Turchia 3
ZA - Sudafrica 3
AL - Albania 2
HK - Hong Kong 2
IN - India 2
IR - Iran 2
MX - Messico 2
TH - Thailandia 2
BD - Bangladesh 1
CZ - Repubblica Ceca 1
KE - Kenya 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
TG - Togo 1
Totale 2.284
Città #
Southend 711
Chandler 129
Beijing 66
Ashburn 63
Houston 62
Singapore 62
Dublin 57
Ann Arbor 54
Woodbridge 49
Verona 42
Jacksonville 35
New York 29
Wilmington 29
Jinan 20
Helsinki 18
Lawrence 17
Princeton 17
Nanjing 16
Dearborn 13
Seoul 12
Lancaster 11
Hebei 10
Cagliari 9
Milan 9
Redmond 9
Tokyo 9
Boardman 8
Nikaia 8
Ningbo 8
Dallas 7
Dong Ket 7
Nanchang 7
Accra 6
Brussels 6
Hangzhou 6
Shenyang 6
Changsha 5
Palermo 5
Taizhou 5
Treviso 5
Washington 5
Zhengzhou 5
Bucharest 4
Falls Church 4
Frankfurt am Main 4
Seattle 4
Sindelfingen 4
Toronto 4
Yongin-si 4
Auburn Hills 3
Bologna 3
Catania 3
Denpasar 3
Fuzhou 3
Jakarta 3
Kitchener 3
Lido di Spina 3
Los Angeles 3
Napoli 3
Rome 3
San Paolo 3
Santa Clara 3
Shanghai 3
Taiyuan 3
Alcamo 2
Baltimore 2
Berea 2
Catanzaro 2
Chengdu 2
Chicago 2
Clifton 2
Columbus 2
Coventry 2
Haikou 2
Hong Kong 2
Incheon 2
Lübeck 2
Redwood City 2
San Francisco 2
Tehran 2
Tirana 2
Trento 2
Vigevano 2
Apodaca 1
Arzignano 1
Auckland 1
Avola 1
Bengaluru 1
Bridgewater 1
Bupyeong-gu 1
Cambridge 1
Cardano 1
Clearwater 1
Cleveland 1
Corona 1
Cosenza 1
Crotone 1
Denver 1
Desio 1
Dhaka 1
Totale 1.785
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 643
Quantificazione del ruolo svolto dai principali fattori determinanti la glicemia durante un pasto misto, nei pazienti affetti da diabete mellito tipo 1 in terapia con microinfusore insulinico associato a glucosensore 143
Metabolic Effects of Exercise 141
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial. 136
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 134
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 111
Glycated haemoglobin is inversely related to serum vitamin d levels in type 2 diabetic patients. 110
Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program. 105
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 103
A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy 99
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 98
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 94
Gli iperandrogenismi nella donna in post-menopausa 90
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 86
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 82
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 75
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 55
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 34
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10 5
Totale 2.344
Categoria #
all - tutte 6.649
article - articoli 3.941
book - libri 0
conference - conferenze 1.935
curatela - curatele 0
other - altro 354
patent - brevetti 0
selected - selezionate 0
volume - volumi 419
Totale 13.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020252 0 0 0 0 35 35 27 18 16 53 32 36
2020/2021291 26 34 23 32 32 27 14 18 20 17 24 24
2021/2022218 29 54 15 16 16 17 7 14 8 4 14 24
2022/2023349 29 55 21 52 31 87 3 21 31 4 7 8
2023/2024286 10 22 17 24 23 67 7 19 4 35 46 12
2024/2025213 26 28 30 106 23 0 0 0 0 0 0 0
Totale 2.344